Close
CDMO Safety Testing 2026
Novotech

Critical Medicines Act Proposed By EU To Boost Drug Access

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Quantum Simulation Improving Molecular Drug Design

Advancements in quantum mechanical modeling are revolutionizing the way pharmaceutical scientists engineer new therapeutic agents. By providing a high-fidelity simulation of electronic structures and molecular dynamics, these tools enable the precise design of compounds tailored to specific biological targets. This transition from traditional experimental screening to digital molecular architecture is accelerating the development of highly potent and selective medicines, fundamentally changing the landscape of pharmaceutical innovation and computational chemistry.

Quantum Algorithms Transforming Pharma Data Analysis

The pharmaceutical industry is entering a new era of data-driven discovery where traditional analytical methods are being augmented by quantum-enhanced logic. By utilizing specialized mathematical frameworks, researchers can now process massive, high-dimensional datasets with a speed and depth that classical systems cannot match. This transformation is streamlining clinical workflows, optimizing drug-to-patient matching, and revealing hidden patterns within biological data, paving the way for more efficient research and faster therapeutic breakthroughs.

Quantum Computing Accelerating Drug Discovery Models

Integrating quantum mechanics into pharmaceutical research marks a paradigm shift in how scientists identify and develop therapeutic compounds. By leveraging the principles of superposition and entanglement, researchers can simulate molecular interactions with unprecedented accuracy, bypassing the limitations of traditional binary computation. This evolution promises to drastically reduce the time and capital required to bring life-saving drugs to market while opening new doors for treating complex diseases that have long remained elusive.
- Advertisement -

A group involving 19 European Union member countries is pushing for steps to lessen the blocโ€™s dependence when it comes to Chinese imports as far as pharmaceutical ingredients are concerned, according to a paper dated May 2.

This move comes after a week of the European Commission proposing an overhaul of its 136-billion-euro pharmaceutical sector.

The proposed bill of the commission looks to revive the investment, reduce the shortage, and at the same time boost access to affordable drugs in a scenario where health budgets have been pushed to their limits due to the costs involved in the treatment of COVID-19. That said, the countries that are backing the said paper, which include the likes of France, Belgium, Spain, and Germany, want the EU to take more efficient steps in order to bolster the security of supplies when it comes to vital drug ingredients with the Critical Medicines Act.

The countries happen to be concerned when it comes to the global reliance on China in terms of key ingredients and just a handful of manufacturers. It is well to be noted that just five sites manufacture more than 50% of the total ingredients that meet the European benchmark.

As per the paper, the EU is becoming more and more dependent on imports from a few manufacturers as well as regions. Apparently, in 2019, across the world, above 40% of the APIs were sourced from China. Besides, all the API producers are dependent on China when it comes to intermediate inputs.

The commission is looking to roll out a list of critical medicines that require more tracking to make sure that shortages are avoided across the EU. The paper opines that for these medicines, the supply has to be monitored, the global value chains have to be mapped, and suppliers who show potential as well as vulnerabilities should be identified. The list is going to begin with those medications that have consistently been in short supply. The countries will also like to gauge measures that allow EU states to be dependent on one another in cases where no substitute supplies or drugs are found.

Latest stories

Related stories

Quantum Simulation Improving Molecular Drug Design

Advancements in quantum mechanical modeling are revolutionizing the way pharmaceutical scientists engineer new therapeutic agents. By providing a high-fidelity simulation of electronic structures and molecular dynamics, these tools enable the precise design of compounds tailored to specific biological targets. This transition from traditional experimental screening to digital molecular architecture is accelerating the development of highly potent and selective medicines, fundamentally changing the landscape of pharmaceutical innovation and computational chemistry.

Quantum Algorithms Transforming Pharma Data Analysis

The pharmaceutical industry is entering a new era of data-driven discovery where traditional analytical methods are being augmented by quantum-enhanced logic. By utilizing specialized mathematical frameworks, researchers can now process massive, high-dimensional datasets with a speed and depth that classical systems cannot match. This transformation is streamlining clinical workflows, optimizing drug-to-patient matching, and revealing hidden patterns within biological data, paving the way for more efficient research and faster therapeutic breakthroughs.

Quantum Computing Accelerating Drug Discovery Models

Integrating quantum mechanics into pharmaceutical research marks a paradigm shift in how scientists identify and develop therapeutic compounds. By leveraging the principles of superposition and entanglement, researchers can simulate molecular interactions with unprecedented accuracy, bypassing the limitations of traditional binary computation. This evolution promises to drastically reduce the time and capital required to bring life-saving drugs to market while opening new doors for treating complex diseases that have long remained elusive.

Glass vs Polymer: Choosing the Right Material for Parenteral Packaging

In the pharmaceutical industry, material selection plays a critical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป